Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders
Alba Di Pardo(Istituto Neurologico Mediterraneo), Vittorio Maglione(University of Alberta)
Cited by 77
Related Papers
Impaired Ganglioside Metabolism in Huntington's Disease and Neuroprotective Role of GM1
|Journal of Neuroscience|2010|142
Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease
|Scientific Reports|2017|78